FindTrial
Sign In

A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic Rhinitis

A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic Rhinitis

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221872
Enrollment
Unknown
Registered
2012-08-01
Start date
2012-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

investigational material(s) Generic name etc : S-524101 INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational mater

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have a history of symptomatic allergic rhinitis for two or more years. Patients who are positive for allergy tests for house dust mite.

Exclusion criteria

Exclusion criteria: Patients with allergic rhinitis, conjunctivitis or asthma due to other antigens which could confound accurate symptom assessment during study.

Design outcomes

Primary

MeasureTime frame
Efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026